This mirrors the renal cystic disease observed in human TSC cases, where cysts continue to express tuberin and hamartin, differing significantly from the mechanism underlying the formation of angiomyolipomas, which exhibit inactivating mutations and Tsc gene expression loss [83]. The gene discussed is TSC2; the disease is tuberous sclerosis.